# ORTHO REGENERATIVE TECHNOLOGIES INC.: Form D filings

ORTHO REGENERATIVE TECHNOLOGIES INC., a biotechnology company in Kirkland, Quebec, Canada, filed 2 Form D notices with the SEC between 2017 and 2020. The latest, on October 15, 2020, reports $73,394 sold of a $73,394 offering to 2 investors.

Find out what ORTHO REGENERATIVE TECHNOLOGIES INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20ORTHO%20REGENERATIVE%20TECHNOLOGIES%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=ORTHO%20REGENERATIVE%20TECHNOLOGIES%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fortho-regenerative-technologies-inc-1723032)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20ORTHO%20REGENERATIVE%20TECHNOLOGIES%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=ORTHO%20REGENERATIVE%20TECHNOLOGIES%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fortho-regenerative-technologies-inc-1723032)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 16667 BOUL HYMUS, Kirkland, Quebec, Canada, H9H 4
- Phone: (514) 693-8832
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Canada (Federal Level)
- Revenue range: Not Applicable
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1723032

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 15, 2020 | New notice | $73,394 | $73,394 | $0 | 2 | Sep 1, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1723032/000172303220000001/0001723032-20-000001-index.htm) |
| Nov 27, 2017 | New notice | $50,000 | $50,000 | $0 | 1 | Oct 31, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1723032/000117184317007289/0001171843-17-007289-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Michael Atkin | Director |  |
| LeDuc Claude | Executive Officer, Director |  |
| Steve Saviuk | Director |  |
| Michael Buschmann | Director |  |
| Caroline Hoemann | Director |  |
| Tom ES Wright | Director |  |
| Pierre ES Laurin | Director |  |
| Brent ES Norton | Director |  |
| Luc ES Mainville | Executive Officer |  |
| Guy Paul ES Allard | Executive Officer |  |

[Every Form D from the week of Oct 12, 2020](https://specstream.ai/data/form-d/week/2020-10-12) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what ORTHO REGENERATIVE TECHNOLOGIES INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).